NCT06037915

Brief Summary

The goal of this clinical trial is to evaluate possible differences in airway responses and interventions during intravenous anesthesia for direct laryngoscopy in children when comparing two oxygenation methods (conventional low flow oxygen supplementation via nasopharyngeal tube versus Nasal High Flow Therapy with the OptiflowTM system ).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 7, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 14, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

November 28, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2025

Completed
Last Updated

July 9, 2025

Status Verified

July 1, 2025

Enrollment Period

1.5 years

First QC Date

September 7, 2023

Last Update Submit

July 4, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • the incidence of airway interventions

    defined as the need to interrupt the procedure in order to maintain adequate oxygenation with mask ventilation, introduction of a nasopharyngeal airway or intubation with endotracheal tube

    during surgery

  • incidence of desaturation

    defined as pulse oxygen saturation(SpO2) lower than 90% for more than 30 seconds

    during surgery

  • incidence of bradycardia

    defined as a change of 30 percent beyond the baseline of heart rate

    during surgery

  • incidence of tachycardia

    defined as a change of 30 percent beyond the baseline of heart rate

    during surgery

Secondary Outcomes (1)

  • Comparison of the oropharyngeal mucosa before and after the procedure

    before induction of anesthesia and at end of surgery

Study Arms (2)

low flow oxygen

ACTIVE COMPARATOR
Device: low flow oxygen with nasopharyngeal tube

high flow oxygen

ACTIVE COMPARATOR
Device: high flow oxygen with OptiflowTM Nasal High Flow

Interventions

low flow oxygen with nasopharyngeal tube

low flow oxygen

high flow oxygen with OptiflowTM Nasal High Flow

high flow oxygen

Eligibility Criteria

Age1 Month - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • scheduled for elective direct laryngoscopy with surgical intervention
  • written informed consent of the parents or legal guardian

You may not qualify if:

  • refusal of informed consent
  • known allergy for dexmedetomidine
  • known allergy for remifentanil
  • pulse oxygen saturation (SpO2) is lower than 85%, at induction of anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antwerp University Hospital

Edegem, Antwerp, 2650, Belgium

Location

Study Officials

  • Sophie Aerts, MD

    University Hospital, Antwerp

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 7, 2023

First Posted

September 14, 2023

Study Start

November 28, 2023

Primary Completion

May 16, 2025

Study Completion

May 16, 2025

Last Updated

July 9, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations